Clinical Trials Browser

Phase NA × Leukemia, Promyelocytic, Acute × Etoposide × Clear all

NCT05832320 2024-05-10

Optimum Induction Therapy of Low-risk APL

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute